[go: up one dir, main page]

CN103007391B - Predictive adaptive control system for liquid medicament push-injecting - Google Patents

Predictive adaptive control system for liquid medicament push-injecting Download PDF

Info

Publication number
CN103007391B
CN103007391B CN201210553849.2A CN201210553849A CN103007391B CN 103007391 B CN103007391 B CN 103007391B CN 201210553849 A CN201210553849 A CN 201210553849A CN 103007391 B CN103007391 B CN 103007391B
Authority
CN
China
Prior art keywords
module
time
cardiac cycle
medicinal liquid
pressure value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210553849.2A
Other languages
Chinese (zh)
Other versions
CN103007391A (en
Inventor
涂海燕
袁支润
熊瑞平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan University
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University filed Critical Sichuan University
Priority to CN201210553849.2A priority Critical patent/CN103007391B/en
Publication of CN103007391A publication Critical patent/CN103007391A/en
Application granted granted Critical
Publication of CN103007391B publication Critical patent/CN103007391B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

本发明公开了一种用于药液推注的预测自适应控制控制系统,涉及临床手术推药自控技术领域。系统包括包括主控制模块和药液推注模块,药液推注模块包括微控制器和医用注射器,微控制器连接于主控制模块的预测控制算法模块,预测控制算法模块将下一个心动周期的推注时刻发送至微控制器,微控制器控制微推进器进而控制医用注射器的推进速度、推注时刻和推注停止时刻。本发明中药液推注模块中的推药速度、推注时刻、推注停止时刻以及推药量通过主控制模块来控制,提高了药液推注模块的反应速度和实时控制能力,实现了科学、合理、安全用药,即以较少的药物剂量,在局部器官获得最大的药物浓度并停留足够长的时间而无返流,减少伤害健康组织。

The invention discloses a predictive self-adaptive control system for drug liquid injection, and relates to the technical field of automatic control of drug injection in clinical operations. The system includes a main control module and a drug injection module, the drug injection module includes a microcontroller and a medical syringe, the microcontroller is connected to the predictive control algorithm module of the main control module, and the predictive control algorithm module controls the time of the next cardiac cycle The bolus injection time is sent to the microcontroller, and the microcontroller controls the micro propeller to control the advancing speed, bolus injection time and bolus injection stop time of the medical syringe. In the present invention, the medicine pushing speed, the time of injection, the time of stopping the injection and the amount of pushing medicine in the Chinese medicine liquid injection module are controlled by the main control module, which improves the reaction speed and real-time control ability of the medicine liquid injection module, and realizes the Scientific, rational, and safe medication, that is, with a lower drug dose, obtain the maximum drug concentration in the local organs and stay for a long enough time without reflux, reducing damage to healthy tissues.

Description

用于药液推注的预测自适应控制系统Predictive Adaptive Control System for Bolus Injection

技术领域 technical field

本发明涉及临床手术推药自控技术领域,特别涉及一种用于药液推注的预测自适应控制系统。  The invention relates to the technical field of automatic control of medicine pushing in clinical operations, in particular to a predictive self-adaptive control system for medicine liquid injection. the

背景技术 Background technique

目前,临床上对癌症的治疗,普遍采用的是经血管介入注药的化学疗法,即在数字减影X光机(DSA)的监控下穿刺、插管,将导管引入给肿瘤供血动脉分支入口,在导管入口端推注化疗药。该方法最先用于心血管疾病,以后很快应用到神经系统、肿瘤等全身各部位多种疾病诊断与治疗。在我国介入治疗用于肿瘤特别多,已占介入治疗大部分,已成为肿瘤综合治疗中一种常用的疗法。介入方式也从血管性介入到肺动肺介入、支气管动脉介入,腔内介入,肿瘤内直接介入。  At present, in the clinical treatment of cancer, chemotherapy through vascular intervention is commonly used, that is, puncture and catheterization under the monitoring of digital subtraction X-ray machine (DSA), and the catheter is introduced into the entrance of the branch of the tumor blood supply artery. , inject chemotherapy drugs at the inlet end of the catheter. This method was first used for cardiovascular diseases, and was soon applied to the diagnosis and treatment of various diseases in various parts of the body, such as the nervous system and tumors. In my country, interventional therapy is especially used for tumors, accounting for the majority of interventional therapy, and has become a commonly used therapy in comprehensive tumor therapy. The intervention methods also range from vascular intervention to pulmonary-pulmonary intervention, bronchial artery intervention, intracavitary intervention, and direct intratumoral intervention. the

当前临床上经血管介入推药时,普遍存在着只关注肿瘤病灶、癌细胞,因而采取了以消灭癌细胞为目标,用简单手推式注射器进行大剂量、高速灌注的攻击性推药化疗。但利用这种传统手工推药方式时,药液进入血管后便跟随着血管内血液流动方向流向全身各部,无法与病人的血压值、心率等会随着病人自身的调节机制做出反应而改变的参数相联系,使得药液只有部分进入病变肿瘤血管,造成该药液既杀了癌细胞、也杀了正常细胞的结果;并且推药过程中,药液的推进量过大或者速度过快还会引发诸多临床问题,不但增加病人的经济负担,也增加了医护人员的工作量。  At present, in the clinical practice of pushing drugs through blood vessels, it is common to only focus on tumor lesions and cancer cells. Therefore, aggressive drug pushing chemotherapy with large doses and high-speed perfusion is adopted with the goal of destroying cancer cells with a simple hand-push syringe. However, when using this traditional method of manually pushing the medicine, the medicine liquid will follow the blood flow direction in the blood vessel to all parts of the body after entering the blood vessel, which cannot be compared with the patient's blood pressure value, heart rate, etc., which will respond to the patient's own adjustment mechanism. The parameters are connected, so that only part of the liquid medicine enters the tumor blood vessels, resulting in the result that the liquid medicine kills both cancer cells and normal cells; It will also cause many clinical problems, which will not only increase the financial burden of patients, but also increase the workload of medical staff. the

发明内容 Contents of the invention

本发明的目的在于克服现有技术中所存在的上述不足,提供一种可减少伤害健康组织的用于药液推注的预测自适应控制系统。  The purpose of the present invention is to overcome the above-mentioned disadvantages in the prior art, and provide a predictive adaptive control system for drug fluid bolus injection that can reduce damage to healthy tissues. the

为了实现上述发明目的,本发明提供了以下技术方案:  In order to realize the above-mentioned purpose of the invention, the present invention provides the following technical solutions:

一种用于药液推注的预测自适应控制系统,包括主控制模块和药液推注模块,其特征在于,所述主控制模块包括用于采集人体血压值的检测模块,所述检测模块包括血压传感器;所述检测模块将该血压值传递至内存区进行储存,形成血压值数组,所述内存区连接有识别模块,所述识别模块识别内存区的血压值数组得到实时的心动周期及周期中的特征参数,所述识别模块还连接有预测控制算法模块,所述预测控制算法模块通过对特征参数的计算得到下一个心动周期的推注时刻;  A predictive adaptive control system for medicinal liquid bolus injection, comprising a main control module and a medicinal liquid bolus injection module, characterized in that the main control module includes a detection module for collecting human blood pressure values, and the detection module Including a blood pressure sensor; the detection module transmits the blood pressure value to the memory area for storage to form an array of blood pressure values, the memory area is connected to an identification module, and the identification module identifies the blood pressure value array in the memory area to obtain real-time cardiac cycle and The characteristic parameters in the cycle, the identification module is also connected with a predictive control algorithm module, and the predictive control algorithm module obtains the injection time of the next cardiac cycle by calculating the characteristic parameters;

所述药液推注模块连接于主控制模块的预测控制算法模块,所述药液推注模块包括微控制器和医用注射器,所述药液推注模块通过微控制器连接于预测控制算法模块,所述预测控制算法模块将下一个心动周期的推注时刻发送至微控制器,所述微控制器连接有微推进器,所述微推进器连接有医用注射器,所述微控制器控制微推进器的推进速度、推注时刻和推注停止时刻,进而控制医用注射器的注射速度、推注时刻和推注停止时刻;  The medicinal liquid bolus injection module is connected to the predictive control algorithm module of the main control module, the medicinal liquid bolus injection module includes a microcontroller and a medical syringe, and the medicinal liquid bolus injection module is connected to the predictive control algorithm module through the microcontroller , the predictive control algorithm module sends the bolus injection time of the next cardiac cycle to the microcontroller, the microcontroller is connected with a micro-propeller, the micro-propeller is connected with a medical injector, and the micro-controller controls the micro-propeller The propulsion speed, bolus injection time and bolus injection stop time of the propeller, and then control the injection speed, bolus injection time and bolus injection stop time of the medical syringe;

所述系统按照以下步骤处理信号:  The system processes signals according to the following steps:

(1)采集血压值:通过主控制模块中的检测模块实时采集人体血压值,以递推的方式储存至主控制模块中的内存区形成血压值数组;  (1) Collection of blood pressure values: real-time collection of human blood pressure values through the detection module in the main control module, and recursively stored in the memory area of the main control module to form an array of blood pressure values;

(2)得到相关参数:主控制模块中的识别模块通过识别血压值数组得到实时的心动周期及周期中的特征参数;通过体检得到患者的病征参数;  (2) Obtain relevant parameters: the identification module in the main control module obtains the real-time cardiac cycle and the characteristic parameters in the cycle by identifying the array of blood pressure values; obtains the patient's symptom parameters through physical examination;

(3)计算推药时刻:根据病征参数设置推药时刻;主控制模块根据推药时刻、实时的心动周期及周期中的特征参数,通过预测控制算法计算出下一个心动周期中的推药时刻;  (3) Calculating the time to push the medicine: set the time to push the medicine according to the symptom parameters; the main control module calculates the time to push the medicine in the next cardiac cycle through the predictive control algorithm according to the time to push the medicine, the real-time cardiac cycle and the characteristic parameters in the cycle ;

(4)启动药液推注模块:主控制模块将计算出的下一个心动周期中的推药时刻发送至药液推注模块中的微控制器,所述微控制器根据该推药时刻并提前tdelay,启动药液推注模块中微推注器进行药液推注,所述tdelay为药液推注模块的时延;  (4) Start the medicinal solution injection module: the main control module sends the calculated drug pushing time in the next cardiac cycle to the microcontroller in the medicinal solution injection module, and the microcontroller calculates the drug pushing time according to the drug pushing time and Ahead of t delay , start the micro injector in the liquid medicine bolus injection module to carry out the liquid medicine bolus injection, and said t delay is the time delay of the liquid medicine bolus injection module;

(5)推注的自适应:检测模块采集新的血压值,将新得到的采样血压值、新识别出的心动周期及周期中的特征参数与之前采集的血压值、心动周期及周期中的特征参数加权平均,更新预测控制算法的参数,实现药液预测控制推注的自适应性;  (5) Self-adaptation of bolus injection: the detection module collects new blood pressure values, and compares the newly obtained sampled blood pressure values, newly identified cardiac cycle and characteristic parameters in the cycle with the previously collected blood pressure value, cardiac cycle and the characteristic parameters in the cycle. The weighted average of the characteristic parameters updates the parameters of the predictive control algorithm to realize the adaptability of the predictive control bolus injection of medicinal liquid;

步骤(1)中,递推的方式是指采样新血压值进入血压值数组时,同时丢掉一组最早的采样血压值,使血压值数组的维数保持不变;  In step (1), the recursive method means that when sampling a new blood pressure value into the blood pressure value array, a group of earliest sampled blood pressure values are discarded at the same time, so that the dimension of the blood pressure value array remains unchanged;

步骤(2)中,心动周期中的特征参数包括收缩压,舒张压,心舒张期时长、心收缩期时长;病征参数包括肿瘤直径、肿瘤供血动脉、肿瘤距预设的药液推注点距离;  In step (2), the characteristic parameters in the cardiac cycle include systolic blood pressure, diastolic blood pressure, diastolic duration, and systolic duration; symptom parameters include tumor diameter, tumor blood supply artery, distance between the tumor and the preset drug injection point ;

步骤(3)中,推药时刻是指心动周期的特征参数中的一个时相的起始时刻;下一个心动周期中的推药时刻tr(k+1)通过等式tr(k+1)'=tr(k)+Tm(k)+  In step (3), the medicine pushing moment refers to the starting moment of a phase in the characteristic parameters of the cardiac cycle; the medicine pushing moment t r (k+1) in the next cardiac cycle is passed through the equation t r (k+ 1)'=t r (k)+T m (k)+

ξ[(tr(k)-tr(k)',tr(k-1)-tr(k-1)',Ltr(k-m)-tr(k=m)']T来计算,其中,tr(k)为当前心动周期中该时相的起始时刻,即当前的推药时刻;tr(k)'为预测控制算法根据上一次心动周期中的特征参数计算得出的当前心动周期中该时相的起始时刻;Tm(k)为灰色预测模型GM(1,1)根据之前的心动周期波动规律计算出的当前 心动周期的时长;m为预测时域长度,且m>0;ξ为误差系数向量,决定各误差分量的权重,ξ=[ξ1 ξ2 L ξn],0<ξn<1,n=1,2,3,…,m;  ξ[(t r (k)-t r (k)',t r (k-1)-t r (k-1)',Lt r (km)-t r (k=m)'] T to Calculation, where, t r (k) is the initial moment of this phase in the current cardiac cycle, that is, the current drug pushing moment; t r (k)' is calculated by the predictive control algorithm based on the characteristic parameters in the last cardiac cycle T m (k) is the duration of the current cardiac cycle calculated by the gray prediction model GM(1,1) according to the fluctuation law of the previous cardiac cycle; m is the predicted time domain length, and m>0; ξ is the error coefficient vector, which determines the weight of each error component, ξ=[ξ 1 ξ 2 L ξ n ], 0<ξ n <1, n=1, 2, 3,..., m ;

灰色预测模型GM(1,1)的具体实现如下:  The specific implementation of the gray prediction model GM(1,1) is as follows:

设心动周期原始数据列为T0(k)(k=1,2,Ln),T1(k)(k=1,2,Ln)为T0(k)一次累加和,即 T 1 ( k ) = &Sigma; j = 1 k T 0 ( j ) ; Let the original data of the cardiac cycle be listed as T 0 (k) (k=1,2,Ln), and T 1 (k) (k=1,2,Ln) is the accumulated sum of T 0 (k), that is T 1 ( k ) = &Sigma; j = 1 k T 0 ( j ) ;

灰度模型微分方程为T(0)(k)+aT(1)(k)=b k=1,2,Ln;n>0;令 Y = T 0 ( 2 ) T 0 ( 3 ) M T 0 ( n ) , 而待辨识的参数为θ=[a,b]T,  The differential equation of the gray model is T (0) (k)+aT (1) (k)=b k=1,2,Ln; n>0; let Y = T 0 ( 2 ) T 0 ( 3 ) m T 0 ( no ) , And the parameter to be identified is θ=[a,b] T ,

B = - ( T 0 ( 1 ) + T 0 ( 2 ) ) / 2 1 - ( T 0 ( 2 ) + T 0 ( 3 ) ) / 2 1 M - ( T 0 ( n - 1 ) + T 0 ( n ) ) / 2 1 , θ=(BTB)-1BTY,得到预测表达式T0(k+1)=T1(k+1)-T1(K)=(1-exp(a))[T0(1)-b/a]exp(-ak),上式中当k<n时,预测输出T原始数据列的还原值T0(k),当k=n时,预测输出T下一时刻的预测输出值,当k>n时,预测输出T的k+n个心动周期之后的预测输出值。  make B = - ( T 0 ( 1 ) + T 0 ( 2 ) ) / 2 1 - ( T 0 ( 2 ) + T 0 ( 3 ) ) / 2 1 m - ( T 0 ( no - 1 ) + T 0 ( no ) ) / 2 1 , θ=(B T B) -1 B T Y, the prediction expression T 0 (k+1)=T 1 (k+1)-T 1 (K)=(1-exp(a))[T 0 (1)-b/a]exp(-ak), when k<n in the above formula, predict the restored value T 0 (k) of the output T original data column, when k=n, predict the output T at the next moment The predicted output value of T, when k>n, the predicted output value after k+n cardiac cycles of predicted output T.

优选的,上述用于药液推注的预测自适应控制系统中,所述药液推注模块中的微控制器连接于主控制模块的预测控制算法模块;所述微推进器包括外壳和步进电机,所述步进电机通过联轴器连接有丝杆,所述丝杆另一端固定于与步进电机相对的一侧,所述丝杆连接有针筒顶头;所述医用注射器固定于所述微推进器的外壳,所述医用注射器的活塞杆尾端与所述针筒顶头的位置相适配。步进电机通过联轴器带动针筒顶头运动,丝杆可将联轴器的旋转运动转换为针 筒顶头的直线运动,从而使针筒顶头可推动活塞杆推注药液。  Preferably, in the above-mentioned predictive adaptive control system for medicinal liquid bolus injection, the microcontroller in the medicinal liquid bolus injection module is connected to the predictive control algorithm module of the main control module; The stepping motor is connected to a screw rod through a coupling, and the other end of the screw rod is fixed on the side opposite to the stepping motor, and the screw rod is connected to a syringe plug; the medical syringe is fixed on The shell of the micro propeller, the tail end of the piston rod of the medical syringe is adapted to the position of the top of the syringe. The stepper motor drives the head of the syringe to move through the coupling, and the screw rod can convert the rotational motion of the coupling into the linear motion of the head of the syringe, so that the head of the syringe can push the piston rod to inject the liquid medicine. the

优选的,上述用于药液推注的预测自适应控制系统中,所述微推进器外壳上还设置有用于限制针筒顶头移动的第一限位开关和第二限位开关,当针筒内活塞与针筒顶端接触时,所述第一限位开关与针筒顶头接触,所述第一限位开关与第二限位开关之间的距离小于针筒长度,且第二限位开关位于活塞杆的运动方向并远离针筒的一侧。  Preferably, in the above-mentioned predictive adaptive control system for bolus injection of medicinal liquid, the housing of the micro-propeller is also provided with a first limit switch and a second limit switch for limiting the movement of the syringe head, when the syringe When the inner piston is in contact with the top of the syringe, the first limit switch is in contact with the top of the syringe, the distance between the first limit switch and the second limit switch is less than the length of the syringe, and the second limit switch Located in the direction of movement of the piston rod and away from the side of the barrel. the

优选的,上述用于药液推注的预测自适应控制系统中,所述第一限位开关和第二限位开关连接有报警装置。第一限位开关在与针筒顶头接触时进行报警,通知医护人员针筒内药液注射完毕,可提醒医护人员及时更换针筒。第二限位开关与针筒顶头接触时进行报警,提醒医护人员针筒内的活塞杆已到达最后位置。  Preferably, in the above-mentioned predictive adaptive control system for bolus injection of medicinal fluid, the first limit switch and the second limit switch are connected with an alarm device. When the first limit switch is in contact with the top of the syringe, an alarm is issued to notify the medical staff that the injection of the medicinal liquid in the syringe is completed, and the medical staff can be reminded to replace the syringe in time. When the second limit switch is in contact with the top of the syringe, an alarm is given to remind the medical personnel that the piston rod in the syringe has reached the final position. the

优选的,上述用于药液推注的预测自适应控制系统中,所述针筒顶头与所述活塞杆尾端之间还设置有压力应变片。微控制器通过压力应变片感知的压力进行计算,并控制步进电机的速度,使得步进电机的推进力与血压回推力相平衡,在不进行药液推注时,可避免药液被推出针筒且血液也不会回流,处于压力平衡状态。  Preferably, in the above-mentioned predictive adaptive control system for bolus injection of medicinal liquid, a pressure strain gauge is further provided between the top of the syringe and the tail end of the piston rod. The microcontroller calculates the pressure sensed by the pressure strain gauge, and controls the speed of the stepping motor, so that the thrust of the stepping motor is balanced with the back thrust of the blood pressure, and the liquid medicine can be prevented from being pushed out when the liquid medicine is not injected. The needle barrel and the blood will not flow back, and it is in a state of pressure balance. the

药液推注模块中的推药速度以及推药量通过主控制模块来控制,提高了药液推注模块的反应速度和实时控制能力,并能实现在血流速度缓慢的心舒张期时相进行药液的推注,使得药液进入人体血管时不被高速的血流迅速稀释,从而保持较高浓度,更利于药液杀死癌细胞,因而实现了科学、合理、安全用药,即以较少的药物剂量,在局部器官获得最大的药物浓度并停留足够长的时间而无返流,减少伤害健康组织。不仅改变了当前经血管介入推药中靠手工推注不 可忽视的不规范、高速、大剂量注药而引发的诸多临床问题,还极大地减轻了国家和病人的经济负担、减少了医务人员体力和精力。  The speed and amount of drug pushing in the drug injection injection module are controlled by the main control module, which improves the reaction speed and real-time control ability of the drug injection injection module, and can realize the diastolic phase phase when the blood flow velocity is slow. The bolus injection of the medicinal liquid prevents the medicinal liquid from being rapidly diluted by the high-speed blood flow when it enters the blood vessels of the human body, thereby maintaining a higher concentration, which is more conducive to the medicinal liquid killing cancer cells, thus realizing scientific, rational and safe drug use, that is, with With less drug dose, the maximum drug concentration can be obtained in local organs and stay long enough without reflux, reducing damage to healthy tissues. Not only has it changed many clinical problems caused by non-standard, high-speed, and large-dose injections that cannot be ignored by manual bolus injections in the current transvascular interventional drug push, it has also greatly reduced the economic burden on the country and patients, and reduced the number of medical staff. stamina and energy. the

与现有技术相比,本发明的有益效果:  Compared with prior art, beneficial effect of the present invention:

1、本发明中药液推注模块中的推药速度以及推药量通过主控制模块来控制,提高了药液推注模块的反应速度和实时控制能力,并能实现在血流速度缓慢的心舒张期时相进行药液的推注,使得药液进入人体血管时不被高速的血流迅速稀释,从而保持较高浓度,更利于药液杀死癌细胞,因而实现了科学、合理、安全用药,即以较少的药物剂量,在局部器官获得最大的药物浓度并停留足够长的时间而无返流,减少伤害健康组织。  1. The drug pushing speed and the drug pushing amount in the Chinese medicine liquid injection module of the present invention are controlled by the main control module, which improves the response speed and real-time control ability of the medicinal liquid injection module, and can realize that the blood flow speed is slow. The injection of the medicinal solution during the diastolic phase prevents the medicinal solution from being rapidly diluted by the high-speed blood flow when it enters the blood vessels of the human body, thereby maintaining a higher concentration, which is more conducive to the medicinal solution to kill cancer cells, thus achieving a scientific, reasonable, and Safe drug use, that is, to obtain the maximum drug concentration in local organs with a small drug dose and stay for a long enough time without reflux, so as to reduce damage to healthy tissues. the

2、本发明使用微控制器、微推进器和医用注射器等组成药液推注模块,不仅改变了当前经血管介入推药中靠手工推注不可忽视的不规范、高速、大剂量注药而引发的诸多临床问题,还极大地减轻了国家和病人的经济负担、减少了医务人员体力和精力。  2. The present invention uses microcontrollers, micro-propellers, and medical syringes to form a drug injection module, which not only changes the non-standard, high-speed, and large-dose drug injection that cannot be ignored in the current transvascular interventional drug injection. Many clinical problems have also greatly reduced the economic burden on the country and patients, and reduced the physical strength and energy of medical staff. the

3、由于本发明采用预测控制算法进行心动周期及周期中的特征参数的计算,依据解算出的心动周期及周期中的特征参数,预测在下一心动周期中推出的药液进入血管入口处的时相,提前启动药液推注模块,可即时调整推药时刻,避免造成患者的不适而影响治疗后果。  3. Since the present invention uses a predictive control algorithm to calculate the cardiac cycle and the characteristic parameters in the cycle, according to the calculated cardiac cycle and the characteristic parameters in the cycle, the time when the medicinal solution released in the next cardiac cycle enters the blood vessel entrance is predicted. In contrast, starting the drug injection module in advance can adjust the time of pushing the drug in real time, so as to avoid causing discomfort to the patient and affecting the treatment outcome. the

4、由于本发明的推药时刻是根据患者的血压值、心动周期及周期中的特征参数计算的,医护人员在观察推药情况的同时还可看到病人血压的动态波形,可方便医护人员快速处理突发状况。  4. Since the medicine pushing time of the present invention is calculated according to the patient's blood pressure value, cardiac cycle and characteristic parameters in the cycle, the medical staff can also see the dynamic waveform of the patient's blood pressure while observing the medicine pushing situation, which is convenient for the medical staff Quickly handle emergencies. the

附图说明: Description of drawings:

图1为本发明用于药液推注的预测自适应控制系统原理示意图。  Fig. 1 is a schematic diagram of the principle of the predictive adaptive control system for medicinal liquid bolus injection according to the present invention. the

图2为本发明中药液推注模块的结构示意图。  Fig. 2 is a schematic structural view of the traditional Chinese medicine liquid injection module of the present invention. the

图3为本发明用于药液推注的预测自适应控制方法的流程图。  Fig. 3 is a flow chart of the predictive adaptive control method for bolus injection of medicinal liquid according to the present invention. the

图中标记:1-外壳,2-步进电机,3-联轴器,4-第一限位开关,5-第二限位开关,6-丝杆,7-针筒顶头,8-压力应变片,9-活塞杆,10-针筒。  Marks in the figure: 1-housing, 2-stepper motor, 3-coupling, 4-first limit switch, 5-second limit switch, 6-screw, 7-syringe head, 8-pressure Strain gauge, 9-piston rod, 10-needle. the

具体实施方式 Detailed ways

下面结合试验例及具体实施方式对本发明作进一步的详细描述。但不应将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明内容所实现的技术均属于本发明的范围。  The present invention will be further described in detail below in conjunction with test examples and specific embodiments. However, it should not be understood that the scope of the above subject matter of the present invention is limited to the following embodiments, and all technologies realized based on the content of the present invention belong to the scope of the present invention. the

实施例  Example

一种用于药液推注的预测自适应控制系统,如图1所示,包括主控制模块和药液推注模块,所述主控制模块包括用于采集人体血压值的检测模块,所述检测模块将该血压值传递至内存区进行储存,形成血压值数组,所述内存区连接有识别模块,所述识别模块识别内存区的血压值数组得到实时的心动周期及周期中的特征参数,所述识别模块还连接有预测控制算法模块,所述预测控制算法模块通过对特征参数的计算得到下一个心动周期的推注时刻;  A predictive adaptive control system for medicinal liquid bolus injection, as shown in Figure 1, includes a main control module and a medicinal liquid bolus injection module, the main control module includes a detection module for collecting human blood pressure values, the The detection module transmits the blood pressure value to the memory area for storage to form an array of blood pressure values. The memory area is connected to an identification module, and the identification module identifies the blood pressure value array in the memory area to obtain real-time cardiac cycle and characteristic parameters in the cycle. The identification module is also connected with a predictive control algorithm module, and the predictive control algorithm module obtains the bolus injection time of the next cardiac cycle by calculating the characteristic parameters;

所述药液推注模块连接于主控制模块的预测控制算法模块,所述药液推注模块包括微控制器和医用注射器,所述药液推注模块通过微控制器连接于预测控制算法模块,所述预测控制算法模块将下一个心动周期的推注时刻发送至微控制器,所述微控制器连接有微推进器,所述微推进器连接有医用注射器,所述微控制器控制微推进器的推进速度、推注时刻和推注停止时刻,进而控制医 用注射器的注射速度、推注时刻和推注停止时刻。  The medicinal liquid bolus injection module is connected to the predictive control algorithm module of the main control module, the medicinal liquid bolus injection module includes a microcontroller and a medical syringe, and the medicinal liquid bolus injection module is connected to the predictive control algorithm module through the microcontroller , the predictive control algorithm module sends the bolus injection time of the next cardiac cycle to the microcontroller, the microcontroller is connected with a micro-propeller, the micro-propeller is connected with a medical injector, and the micro-controller controls the micro-propeller The propulsion speed, injection timing and injection stop timing of the propeller, and then control the injection speed, injection injection timing and injection stop timing of the medical syringe. the

药液推注模块包括微控制器、微推进器和医用注射器,所述微控制器连接于主控制模块的预测控制算法模块;如图2所示,所述微推进器包括外壳1和步进电机2,所述步进电机2通过联轴器3连接有丝杆6,所述丝杆6另一端固定于与步进电机2相对的一侧,所述丝杆6连接有针筒顶头7;所述医用注射器固定于所述微推进器的外壳1,所述医用注射器的活塞杆9尾端与所述针筒顶头7的位置相适配,所述针筒顶头7与所述活塞杆9尾端之间还设置有压力应变片8;所述微推进器外壳1内还设置有用于限制针筒顶头7移动的第一限位开关4和第二限位开关5,当针筒10内活塞与针筒顶端接触时,所述第一限位开关4与针筒顶头7接触,所述第一限位开关4与第二限位开关5之间的距离小于针筒10长度,且第二限位开关5位于活塞杆9的运动方向并远离针筒10的一侧;  The medicinal solution bolus injection module includes a microcontroller, a micro-propeller and a medical injector, and the microcontroller is connected to the predictive control algorithm module of the main control module; as shown in Figure 2, the micro-propeller includes a housing 1 and a stepper Motor 2, the stepper motor 2 is connected with a screw rod 6 through a coupling 3, the other end of the screw rod 6 is fixed on the side opposite to the stepper motor 2, and the screw rod 6 is connected with a syringe plug 7 The medical syringe is fixed on the shell 1 of the micro-propeller, the piston rod 9 tail end of the medical syringe is adapted to the position of the syringe top 7, and the syringe top 7 and the piston rod A pressure strain gauge 8 is also provided between the 9 tail ends; a first limit switch 4 and a second limit switch 5 for limiting the movement of the syringe top 7 are also provided in the micro-propeller housing 1, when the syringe 10 When the inner piston is in contact with the top of the syringe, the first limit switch 4 is in contact with the top of the syringe 7, the distance between the first limit switch 4 and the second limit switch 5 is less than the length of the syringe 10, and The second limit switch 5 is located in the direction of movement of the piston rod 9 and away from the side of the syringe 10;

当主控制模块通过预测控制算法模块向药液推注模块发送下一个心动周期的推药时刻时,微控制器启动步进电机带动联轴器旋转,并通过丝杆将旋转运动转变为直线运动,带动针筒顶头使活塞杆运动,推动针筒内的药液进入人体;压力应变片用于感应推注药液时所遇的阻力,并将该阻力发送至微控制器,通过推力的大小判断药液进入人体时血管遇到的阻力;当针筒顶头接触第一限位开关时,发出警报通知医护人员注射完毕,当针筒顶头接触第二限位开关时,发出警报通知医护人员活塞杆到达最后位置。步进电机在药液推注任务开始后,不进行药液推注时,处于低速状态,微控制器通过压力应变片感知的压力进行计算,并控制步进电机的速度,使得步进电机的推进力与血压回推力相平衡,在不进行药液推注时,可避免药液被推出针筒且血液也不会回流,处于压力平衡状态。  When the main control module sends the medicine pushing time of the next cardiac cycle to the medicine injection module through the predictive control algorithm module, the microcontroller starts the stepping motor to drive the coupling to rotate, and converts the rotational movement into a linear movement through the screw rod. Drive the top of the syringe to move the piston rod, and push the medicinal liquid in the syringe into the human body; the pressure strain gauge is used to sense the resistance encountered when injecting the medicinal liquid, and send the resistance to the microcontroller, and judge by the magnitude of the thrust The resistance encountered by blood vessels when the liquid medicine enters the human body; when the top of the syringe touches the first limit switch, an alarm will be sent to inform the medical staff that the injection is completed; when the top of the syringe touches the second limit switch, an alarm will be issued to notify the medical staff of the piston rod Reach the last position. The stepper motor is in a low-speed state when the drug solution injection task starts, and when the drug solution injection is not performed, the microcontroller calculates the pressure sensed by the pressure strain gauge and controls the speed of the stepper motor so that the stepper motor The propulsion force is balanced with the blood pressure return thrust. When the liquid medicine is not injected, it can prevent the liquid medicine from being pushed out of the syringe and the blood will not flow back, and it is in a state of pressure balance. the

如图3所示,上述用于药液推注的预测自适应控制系统按照以下步骤处理 信号:  As shown in Figure 3, the above-mentioned predictive adaptive control system for the injection of medicinal liquid processes the signal according to the following steps:

(1)采集血压值:通过主控制模块中的检测模块实时采集人体血压值,以递推的方式储存至主控制模块中的内存区形成血压值数组;  (1) Collection of blood pressure values: real-time collection of human blood pressure values through the detection module in the main control module, and recursively stored in the memory area of the main control module to form an array of blood pressure values;

(2)得到相关参数:主控制模块中的识别模块通过识别血压值数组得到实时的心动周期及周期中的特征参数;通过体检得到患者的病征参数;  (2) Obtain relevant parameters: the identification module in the main control module obtains the real-time cardiac cycle and the characteristic parameters in the cycle by identifying the array of blood pressure values; obtains the patient's symptom parameters through physical examination;

(3)计算推药时刻:根据病征参数设置推药时刻;主控制模块根据推药时刻、实时的心动周期及周期中的特征参数,通过预测控制算法计算出下一个心动周期中的推药时刻;  (3) Calculating the time to push the medicine: set the time to push the medicine according to the symptom parameters; the main control module calculates the time to push the medicine in the next cardiac cycle through the predictive control algorithm according to the time to push the medicine, the real-time cardiac cycle and the characteristic parameters in the cycle ;

(4)启动药液推注模块:主控制模块将计算出的下一个心动周期中的推药时刻发送至药液推注模块中的微控制器,所述微控制器根据该推药时刻并提前tdelay,启动药液推注模块中微推注器进行药液推注,所述tdelay为药液推注模块的时延;  (4) Start the medicinal solution injection module: the main control module sends the calculated drug pushing time in the next cardiac cycle to the microcontroller in the medicinal solution injection module, and the microcontroller calculates the drug pushing time according to the drug pushing time and Ahead of t delay , start the micro injector in the liquid medicine bolus injection module to carry out the liquid medicine bolus injection, and said t delay is the time delay of the liquid medicine bolus injection module;

(5)推注的自适应:检测模块采集新的血压值,将新得到的采样血压值、新识别出的心动周期及周期中的特征参数与之前采集的血压值、心动周期及周期中的特征参数加权平均,更新预测控制算法的参数,实现药液预测控制推注的自适应性。  (5) Self-adaptation of bolus injection: the detection module collects new blood pressure values, and compares the newly obtained sampled blood pressure values, newly identified cardiac cycle and characteristic parameters in the cycle with the previously collected blood pressure value, cardiac cycle and the characteristic parameters in the cycle. The weighted average of the characteristic parameters is used to update the parameters of the predictive control algorithm to realize the adaptability of the predictive control bolus injection of medicinal liquid. the

推药时刻根据患者的血压值、心动周期及周期中的特征参数相关联,可即时调整推药时刻,避免造成患者的不适而影响治疗后果。  The medicine pushing time is related to the patient's blood pressure value, cardiac cycle and the characteristic parameters in the cycle, and the medicine pushing time can be adjusted in real time to avoid causing discomfort to the patient and affecting the treatment outcome. the

步骤(1)中,检测模块包括血压传感器;递推的方式是指采样新血压值进入血压值数组时,同时丢掉一组最早的采样血压值,使血压值数组的维数保持不变。  In step (1), the detection module includes a blood pressure sensor; the recursive method means that when sampling a new blood pressure value into the blood pressure value array, a group of earliest sampled blood pressure values are discarded at the same time, so that the dimension of the blood pressure value array remains unchanged. the

步骤(2)中,心动周期中的特征参数包括收缩压,舒张压,心舒张期时长、心收缩期时长等;病征参数包括肿瘤直径、肿瘤供血动脉、肿瘤距预设的药液推注点距离等。  In step (2), the characteristic parameters in the cardiac cycle include systolic blood pressure, diastolic blood pressure, diastolic period duration, systolic period duration, etc.; symptom parameters include tumor diameter, tumor blood supply artery, tumor distance from the preset drug injection point distance etc. the

步骤(3)中,推药时刻是指心动周期的特征参数中的一个时相的起始时刻;下一个心动周期中的推药时刻tr(k+1)通过等式tr(k+1)'=tr(k)+Tm(k)+  In step (3), the medicine pushing moment refers to the starting moment of a phase in the characteristic parameters of the cardiac cycle; the medicine pushing moment t r (k+1) in the next cardiac cycle is passed through the equation t r (k+ 1)'=t r (k)+T m (k)+

ξ[(tr(k)-tr(k)',tr(k-1)-tr(k-1)',Ltr(k-m)-tr(k=m)']T来计算,其中,tr(k)为当前心动周期中该时相的起始时刻,即当前的推药时刻;tr(k)'为预测控制算法根据上一次心动周期中的特征参数计算得出的当前心动周期中该时相的起始时刻;Tm(k)为灰色预测模型GM(1,1)根据之前的心动周期波动规律计算出的当前心动周期的时长;m为预测时域长度,且m>0;ξ为误差系数向量,决定各误差分量的权重,ξ=[ξ1 ξ2 L ξn],0<ξn<1,n=1,2,3,…,m。  ξ[(t r (k)-t r (k)',t r (k-1)-t r (k-1)',Lt r (km)-t r (k=m)'] T to Calculation, where, t r (k) is the initial moment of this phase in the current cardiac cycle, that is, the current drug pushing moment; t r (k)' is calculated by the predictive control algorithm based on the characteristic parameters in the last cardiac cycle T m (k) is the duration of the current cardiac cycle calculated by the gray prediction model GM(1,1) according to the fluctuation law of the previous cardiac cycle; m is the predicted time domain length, and m>0; ξ is the error coefficient vector, which determines the weight of each error component, ξ=[ξ 1 ξ 2 L ξ n ], 0<ξ n <1, n=1, 2, 3,..., m .

灰色预测模型GM(1,1)的具体实现如下:  The specific implementation of the gray prediction model GM(1,1) is as follows:

设心动周期原始数据列为T0(k)(k=1,2,Ln),T1(k)(k=1,2,Ln)为T0(k)一次累加和,即 T 1 ( k ) = &Sigma; j = 1 k T 0 ( j ) ; Let the original data of the cardiac cycle be listed as T 0 (k) (k=1,2,Ln), and T 1 (k) (k=1,2,Ln) is the accumulated sum of T 0 (k), that is T 1 ( k ) = &Sigma; j = 1 k T 0 ( j ) ;

灰度模型微分方程为T(0)(k)+aT(1)(k)=b k=1,2,Ln;n>0;令 Y = T 0 ( 2 ) T 0 ( 3 ) M T 0 ( n ) , 而待辨识的参数为θ=[a,b]T,  The differential equation of the gray model is T (0) (k)+aT (1) (k)=b k=1,2,Ln; n>0; let Y = T 0 ( 2 ) T 0 ( 3 ) m T 0 ( no ) , And the parameter to be identified is θ=[a,b] T ,

B = - ( T 0 ( 1 ) + T 0 ( 2 ) ) / 2 1 - ( T 0 ( 2 ) + T 0 ( 3 ) ) / 2 1 M - ( T 0 ( n - 1 ) + T 0 ( n ) ) / 2 1 , θ=(BTB)-1BTY,得到预测表达式 T0(k+1)=T1(k+1)-T1(K)=(1-exp(a))[T0(1)-b/a]exp(-ak),上式中当k<n时,预测输出T原始数据列的还原值T0(k),当k=n时,预测输出T下一时刻的预测输出值,当k>n时,预测输出T的k+n个心动周期之后的预测输出值。  make B = - ( T 0 ( 1 ) + T 0 ( 2 ) ) / 2 1 - ( T 0 ( 2 ) + T 0 ( 3 ) ) / 2 1 m - ( T 0 ( no - 1 ) + T 0 ( no ) ) / 2 1 , θ=(B T B) -1 B T Y, get the prediction expression T 0 (k+1)=T 1 (k+1)-T 1 (K)=(1-exp(a))[T 0 (1)-b/a]exp(-ak), when k<n in the above formula, predict the restored value T 0 (k) of the output T original data column, when k=n, predict the output T at the next moment The predicted output value of T, when k>n, the predicted output value after k+n cardiac cycles of predicted output T.

Claims (5)

1. a prediction adaptive control system of injecting for medicinal liquid, comprises that main control module and medicinal liquid inject module, it is characterized in that, described main control module comprises the detection module for gathering human blood-pressure value, and described detection module comprises pressure transducer; Described detection module is passed to memory field by this pressure value and stores, form pressure value array, described memory field is connected with identification module, the pressure value array of described identification module identification memory field obtains real-time cardiac cycle and the characteristic parameter in the cycle, described identification module is also connected with predictive control algorithm module, and described predictive control algorithm module is by calculating injecting the moment of next cardiac cycle to characteristic parameter;
The predictive control algorithm module of main control module injected module and is connected in by described medicinal liquid, described medicinal liquid is injected module and is comprised microcontroller and injector for medical purpose, described medicinal liquid is injected module and is connected in predictive control algorithm module by microcontroller, the moment of injecting of next cardiac cycle is sent to microcontroller by described predictive control algorithm module, described microcontroller is connected with micro-thruster, described micro-thruster is connected with injector for medical purpose, the fltting speed of described microprocessor controls micro-thruster, inject the moment and inject and stop the moment, and then the injection speed of control injector for medical purpose, inject the moment and inject and stop the moment,
Described system is according to steps of processing signal:
(1) gather pressure value: by the detection module Real-time Collection human blood-pressure value in main control module, the memory field being stored in main control module in the mode of recursion forms pressure value array;
(2) obtain relevant parameter: the identification module in main control module obtains real-time cardiac cycle and the characteristic parameter in the cycle by identification pressure value array; Obtain patient's symptom parameter by health check-up;
(3) calculate and push away the medicine moment: setting pushes away the medicine moment according to symptom parameter; Main control module, according to pushing away medicine moment, real-time cardiac cycle and the characteristic parameter in the cycle, calculates pushing away the medicine moment in next cardiac cycle by predictive control algorithm;
(4) start medicinal liquid and inject module: main control module is sent to the medicine moment that pushes away in the next cardiac cycle calculating medicinal liquid and injects the microcontroller in module, described microcontroller pushes away medicine moment t in advance according to this delay, start medicinal liquid and inject in module micro-injector and carry out medicinal liquid and inject, described t delayfor medicinal liquid is injected the time delay of module;
(5) self adaptation of injecting: the pressure value that detection module collection is new, the cardiac cycle by the sampling pressure value newly obtaining, newly identifying and the characteristic parameter in the cycle and the pressure value, cardiac cycle and the characteristic parameter weighted average in the cycle that gather before, the parameter of upgrading predictive control algorithm, realizes the adaptivity that medicinal liquid PREDICTIVE CONTROL is injected;
In step (1), the mode of recursion refers to when the new pressure value of sampling enters pressure value array, loses one group of sampling pressure value the earliest simultaneously, and the dimension of pressure value array is remained unchanged;
In step (2), the characteristic parameter in cardiac cycle comprises systolic pressure, diastolic pressure, diastole duration, systolic period duration; Symptom parameter comprises that diameter of tumor, supply artery of the tumor, tumor inject a distance apart from default medicinal liquid;
In step (3), the initial time of phase while pushing away in the characteristic parameter that the medicine moment refers to cardiac cycle; In next cardiac cycle, push away medicine moment t r(k+1) by equation t r(k+1) '=t r(k)+T m(k)+
ξ [(t r(k)-t r(k) ', t r(k-1)-t r(k-1) ', Lt r(k-m)-t r(k=m) '] tcalculate, wherein, t r(k) be in current cardiac cycle this time phase initial time, i.e. current pushing away the medicine moment; t r(k) ' in the current cardiac cycle that draws according to the calculation of characteristic parameters in last cardiac cycle for predictive control algorithm this time phase initial time; T m(k) be Grey models GM (1,1) according to before the duration of the current cardiac cycle that calculates of cardiac cycle fluctuation pattern; Length of field when m is prediction, and m>0; ξ is error coefficient vector, determines the weight of each error component, ξ=[ξ 1ξ 2l ξ n], 0 < ξ n< 1, n=1,2,3 ..., m;
Being implemented as follows of Grey models GM (1,1):
If cardiac cycle initial data is classified T as 0(k) (k=1,2, Ln), T 1(k) (k=1,2, Ln) is T 0(k) one-accumulate and, T 1 ( k ) = &Sigma; j = 1 k T 0 ( j ) ;
The gray level model differential equation is T (0)(k)+aT (1)(k)=b k=1,2, Ln; N>0; Order Y = T 0 ( 2 ) T 0 ( 3 ) M T 0 ( n ) , And parameter to be identified is θ=[a, b] t,
Order B = - ( T 0 ( 1 ) + T 0 ( 2 ) ) / 2 1 - ( T 0 ( 2 ) + T 0 ( 3 ) ) / 2 1 M - ( T 0 ( n - 1 ) + T 0 ( n ) ) / 2 1 , θ=(B tb) -1b ty, obtains prediction expression T 0(k+1)=T 1(k+1)-T 1(K)=(1-exp (a)) [T 0(1)-b/a] exp (ak), in above formula, in the time of k<n, the reducing value T of T initial data row is exported in prediction 0(k), in the time of k=n, the prediction output valve in prediction output next moment of T, in the time of k>n, the prediction output valve after k+n the cardiac cycle of prediction output T.
2. prediction adaptive control system of injecting for medicinal liquid according to claim 1, is characterized in that, the predictive control algorithm module of main control module injected microcontroller in module and be connected in by described medicinal liquid; Described micro-thruster comprises shell and motor, and described motor is connected with screw mandrel by shaft coupling, and the described screw mandrel other end is fixed on a side relative with motor, and described screw mandrel is connected with syringe top; Described injector for medical purpose is fixed on the shell of described micro-thruster, and the position of the piston rod tail end of described injector for medical purpose and described syringe top is suitable.
3. prediction adaptive control system of injecting for medicinal liquid according to claim 2, it is characterized in that, on described micro-thruster shell, be also provided with for limiting mobile the first limit switch and the second limit switch in syringe top, in the time that syringe inner carrier contacts with syringe top, described the first limit switch contacts with syringe top, distance between described the first limit switch and the second limit switch is less than syringe length, and the second limit switch is positioned at the direction of motion of piston rod the side away from syringe.
4. prediction adaptive control system of injecting for medicinal liquid according to claim 3, is characterized in that, described the first limit switch and the second limit switch are connected with alarm device.
5. prediction adaptive control system of injecting for medicinal liquid according to claim 4, is characterized in that, between described syringe top and described piston rod tail end, is also provided with pressure-strain sheet.
CN201210553849.2A 2012-12-19 2012-12-19 Predictive adaptive control system for liquid medicament push-injecting Expired - Fee Related CN103007391B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210553849.2A CN103007391B (en) 2012-12-19 2012-12-19 Predictive adaptive control system for liquid medicament push-injecting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210553849.2A CN103007391B (en) 2012-12-19 2012-12-19 Predictive adaptive control system for liquid medicament push-injecting

Publications (2)

Publication Number Publication Date
CN103007391A CN103007391A (en) 2013-04-03
CN103007391B true CN103007391B (en) 2014-12-03

Family

ID=47956846

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210553849.2A Expired - Fee Related CN103007391B (en) 2012-12-19 2012-12-19 Predictive adaptive control system for liquid medicament push-injecting

Country Status (1)

Country Link
CN (1) CN103007391B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107224635A (en) * 2017-07-01 2017-10-03 苏州能斯达电子科技有限公司 A kind of injection of insulin is pumped monitoring device
CN108992743B (en) * 2018-08-06 2022-01-07 广州友沃医疗设备有限公司 Injection method and device for automatically generating injection plan
CN112741706B (en) * 2019-10-29 2024-05-14 北京大学第三医院(北京大学第三临床医学院) Method and device for preparing diffusion source and method for measuring physiological parameters of extracellular space of solid tissue

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2065486U (en) * 1989-02-27 1990-11-14 罗建明 Micro automatic syringe
CN1482927A (en) * 2000-12-22 2004-03-17 DCA��ƹ������޹�˾ Injection device with replaceable medicament cartridge
CN1561241A (en) * 2001-07-31 2005-01-05 斯科特实验室公司 Apparatuses and methods for titrating drug delivery
CN201643200U (en) * 2010-05-17 2010-11-24 中国人民解放军南京军区南京总医院 Infusion speed adjustment device
CN102247638A (en) * 2011-04-12 2011-11-23 四川大学 Haemodynamics-based forecast self-adaptive injection device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756872B4 (en) * 1997-12-19 2005-06-02 Siemens Ag Device for administering an infusion and / or perfusion to a patient

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2065486U (en) * 1989-02-27 1990-11-14 罗建明 Micro automatic syringe
CN1482927A (en) * 2000-12-22 2004-03-17 DCA��ƹ������޹�˾ Injection device with replaceable medicament cartridge
CN1561241A (en) * 2001-07-31 2005-01-05 斯科特实验室公司 Apparatuses and methods for titrating drug delivery
CN201643200U (en) * 2010-05-17 2010-11-24 中国人民解放军南京军区南京总医院 Infusion speed adjustment device
CN102247638A (en) * 2011-04-12 2011-11-23 四川大学 Haemodynamics-based forecast self-adaptive injection device

Also Published As

Publication number Publication date
CN103007391A (en) 2013-04-03

Similar Documents

Publication Publication Date Title
JP6449483B2 (en) Ischemic preconditioning treatment device, its use, and method of using it to determine vascular health
US20100160854A1 (en) Integrated patient management and control system for medication delivery
CN102247638A (en) Haemodynamics-based forecast self-adaptive injection device
CN103007391B (en) Predictive adaptive control system for liquid medicament push-injecting
CN110770843A (en) System and method for split-bolus regimen generation
CN204839438U (en) Head end has angioscope of sacculus
US9050400B2 (en) Remote sensing catheter system and methods
CN108815642A (en) A kind of opacifying injection system
CN205339754U (en) Novel insulin injection device
CN104825233B (en) Experimental device for frog heart perfusion
CN111790025A (en) A skin test injection mechanism and its control method
CN208756688U (en) A kind of opacifying injection system
CN216021044U (en) Blood glucose meter capable of continuously and dynamically monitoring
CN202822343U (en) Dedicated syringe for treating diabetes mellitus
CN201283161Y (en) Disposal cotton swab for nasal administration
CN114129825A (en) Intelligent anesthesia control system
CN201668848U (en) Novel arterial indwelling needle
CN209187764U (en) A device for vascular interventional therapy
CN112704577A (en) Quantitative continuous anti-biting drencher for veterinarian
CN202027999U (en) Automatic injection device with tension spring
CN112120708A (en) Blood glucose monitoring intelligent device for developing and glucose-regulating 18F-FDG PET surviving cardiac muscle
CN204581449U (en) The diacan of improvement
CN215231089U (en) Cardiovascular intervention injector
CN204468880U (en) One is applicable to infant negative-pressure type quiet/needle of retaining on artery
US20230355871A1 (en) Minimally Invasive and Semi-Automated Myocardial Injection Device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141203